Alisol B acetate is widely studied for its potential therapeutic applications, particularly in the field of metabolic and inflammatory diseases. It has shown significant anti-diabetic effects by enhancing insulin sensitivity and reducing blood glucose levels, making it a candidate for managing type 2 diabetes. The compound also exhibits hepatoprotective properties, helping to reduce liver fat accumulation and inflammation in non-alcoholic fatty liver disease (NAFLD).

In addition, Alisol B acetate demonstrates anti-inflammatory and anti-fibrotic activities, which are beneficial in treating chronic kidney disease and liver fibrosis. It modulates key signaling pathways such as AMPK and NF-κB, contributing to its regulatory effects on metabolism and inflammation.

Emerging research suggests potential anti-cancer activity, particularly in liver and breast cancer cells, where it induces apoptosis and inhibits cell proliferation. Due to these diverse biological effects, Alisol B acetate is considered a promising lead compound for developing natural product-based drugs targeting metabolic disorders, liver diseases, and certain cancers.